Royal Perth Hospital

Futó vizsgálatok

• Még nem toboroz

  Study of CTX001 in Adults With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease

  NCT07901933· 1. fázis· Forrás

• Toboroz

  A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia

  NCT07623200· 3. fázis· Forrás

• Toboroz

  Safety and Efficacy of STL303 In Patients With Primary Immunoglobulin A (IgA) Nephropathy

  NCT07606352· 2. fázis· Forrás

• Toboroz

  Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction

  NCT07362446· 2. fázis· Forrás

• Még nem toboroz

  A Phase II Trial of Tumour Infiltrating Lymphocyte Adoptive Cell Therapy in Patients With Immune Checkpoint Inhibitor Resistant Unresectable or Metastatic Melanoma

  NCT07651618· 2. fázis· Forrás

• Toboroz

  A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

  NCT07518186· 3. fázis· Forrás

• Toboroz

  A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

  NCT07222761· 3. fázis· Forrás

• Toboroz

  PRIORITY-CONNECT 2 Trial

  NCT06976710· Forrás

• Toboroz

  Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension

  NCT07115953· Forrás

• Toboroz

  Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

  NCT06824168· 2. fázis· Forrás

• Toboroz

  A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

  NCT06819878· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy

  NCT06456463· 2. fázis· Forrás

• Toboroz

  ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

  NCT06656494· 1. fázis· Forrás

• Toboroz

  LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

  NCT06632457· 3. fázis· Forrás

• Toboroz

  LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

  NCT06632444· 3. fázis· Forrás

• Toboroz

  A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

  NCT06226883· 2. fázis· Forrás

• Toboroz

  A Study to Investigate APL-4098 Alone and in Combination in Adults With AML or MDS

  NCT06372717· 1. fázis· Forrás

• Toboroz

  Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

  NCT06479135· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Revumenib in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias

  NCT06226571· 1. fázis· Forrás

• Fut, nem toboroz

  A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis

  NCT06254950· 2. fázis· Forrás

• Toboroz

  A Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)

  NCT06163430· 1/2. fázis· Forrás

• Toboroz

  A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

  NCT06233461· 2. fázis· Forrás

• Toboroz

  A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)

  NCT06051409· 3. fázis· Forrás

• Fut, nem toboroz

  Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease

  NCT05701358· Forrás

• Toboroz

  Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  NCT05826535· 1/2. fázis· Forrás

• Fut, nem toboroz

  A Study to Evaluate Migalastat in Fabry Subjects With Amenable GLA Variant and Renal Disease

  NCT04020055· 3. fázis· Forrás

• Toboroz

  4D-310 in Adults With Fabry Disease and Cardiac Involvement

  NCT05629559· 1/2. fázis· Forrás

• Fut, nem toboroz

  A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease

  NCT05347095· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

  NCT05100862· 3. fázis· Forrás

• Toboroz

  HCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Suboptimal Ultrasound Visualisation

  NCT04455932· Forrás

• Toboroz

  A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients.

  NCT03998319· 3. fázis· Forrás

• Toboroz

  A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

  NCT04973605· 1/2. fázis· Forrás

• Fut, nem toboroz

  A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

  NCT04849728· 3. fázis· Forrás

• Toboroz

  A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)

  NCT04811560· 1/2. fázis· Forrás

• Fut, nem toboroz

  Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)

  NCT04662255· 3. fázis· Forrás

• Fut, nem toboroz

  Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

  NCT04666038· 3. fázis· Forrás

• Toboroz

  Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL

  NCT04502394· 1/2. fázis· Forrás

• Fut, nem toboroz

  A Study of the Combination of Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

  NCT04586426· 1/2. fázis· Forrás

• Toboroz

  Study to Evaluate the Safety and Tolerability of EP0042

  NCT04581512· 1/2. fázis· Forrás

• Toboroz

  A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma

  NCT04332822· 3. fázis· Forrás

• Toboroz

  The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study

  NCT04204915· Forrás

• Fut, nem toboroz

  A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies

  NCT03888105· 2. fázis· Forrás

• Fut, nem toboroz

  A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT04033445· 2/3. fázis· Forrás

• Fut, nem toboroz

  A Study to Investigate the Efficacy of Zanubrutinib Plus Rituximab Compared With Bendamustine Plus Rituximab in Adults With Previously Untreated Mantle Cell Lymphoma Who Are Ineligible for Stem Cell Transplantation

  NCT04002297· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Cusatuzumab Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy

  NCT04023526· 2. fázis· Forrás

• Toboroz

  Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress

  NCT03968393· 4. fázis· Forrás

• Fut, nem toboroz

  A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis

  NCT03900429· 3. fázis· Forrás

• Fut, nem toboroz

  A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL

  NCT03336333· 3. fázis· Forrás

• Fut, nem toboroz

  Radiotherapy - Adjuvant Versus Early Salvage

  NCT00860652· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Akut mieloid leukémia (AML)4 toboroz
• Crohn-betegség3 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)3 toboroz
• Mielodiszplasztikus szindróma (MDS)3 toboroz
• Mielóma multiplex3 toboroz
• Koszorúér-betegség2 toboroz
• Krónikus mieloid leukémia (CML)2 toboroz
• Krónikus vesebetegség2 toboroz
• Mieloproliferatív neopláziák2 toboroz
• Zsírmáj (MASLD/MASH)2 toboroz
• Follikuláris limfóma1 toboroz
• Gyermekkori daganatok1 toboroz
• IgA-nefropátia1 toboroz
• Krónikus limfoid leukémia (CLL)1 toboroz
• Magas vérnyomás1 toboroz
• Máj- és epeúti rák1 toboroz
• Melanóma1 toboroz
• Pitvarfibrilláció1 toboroz
• Stroke (szélütés)1 toboroz
• Szívelégtelenség1 toboroz
• Vastagbélrák1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease

  NCT06926660· 2. fázis· Forrás

• Lezárult

  A Phase 1 Study of WU-NK-101 in Patients With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)

  NCT05470140· 1. fázis· Forrás

• Leállították

  Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPA

  NCT05667662· 2. fázis· Forrás

• Lezárult

  ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1

  NCT05507203· 3. fázis· Forrás

• Lezárult

  Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)

  NCT04971785· 2. fázis· Forrás

• Leállították

  Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated

  NCT04778397· 3. fázis· Forrás

• Visszavonták

  A Study of Cusatuzumab in Combination With Azacitidine Compared With Azacitidine Alone in Patients With Higher-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) and Who Are Not Candidates for Hematopoietic Stem Cell Transplantation (HSCT)

  NCT04264806· 2. fázis· Forrás

• Lezárult

  Comprehensive Geriatric Assessment for Frail Older People With Chronic Kidney Disease - The GOAL Trial

  NCT04538157· Forrás

• Lezárult

  Micronised Resveratrol as a Treatment for Friedreich Ataxia

  NCT03933163· 2. fázis· Forrás

• Lezárult

  A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia

  NCT03734016· 3. fázis· Forrás

• Lezárult

  A Study Comparing Obinutuzumab and BGB-3111 Versus Obinutuzumab Alone in Treating R/R Follicular Lymphoma

  NCT03332017· 2. fázis· Forrás

• Lezárult

  Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction.

  NCT01918215· Forrás

• Lezárult

  Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02

  NCT00963417· Forrás

• Lezárult

  Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer

  NCT00819208· Forrás